This extensive study, drawing on data from high-risk participants in the PREDIMED trial, aimed to understand not just that people consume olive oil, but how it changes the body's internal chemistry. Researchers analyzed the unique "chemical fingerprint" left in the bloodstream after consuming different types of olive oil to see if these specific changes could predict the future risk of major chronic diseases.
The key finding centered on heart health. The distinct pattern of metabolites (internal chemicals) associated with consuming total olive oil, and even more so Extra Virgin Olive Oil (EVOO), was strongly and consistently linked to a significantly lower risk of developing cardiovascular disease (CVD), including heart attack and stroke. This shows that the beneficial compounds in olive oil create a protective chemical environment inside the body that fights heart disease.
While the changes in the blood didn't show a definitive link to Type 2 Diabetes risk in this specific analysis, the data reinforced the importance of using high-quality oil. Researchers discovered far more beneficial chemical changes associated with EVOO than with common olive oil, suggesting that the well-preserved natural compounds (like polyphenols) in EVOO are crucial drivers of its protective effects against heart disease.
